DNB Asset Management AS cut its position in HCP, Inc. (NYSE:HCP) by 6.4% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 55,311 shares of the real estate investment trust’s stock after selling 3,755 shares during the period. DNB Asset Management AS’s holdings in HCP were worth $1,731,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently made changes to their positions in HCP. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of HCP in the 3rd quarter valued at approximately $623,000. Renaissance Technologies LLC increased its position in shares of HCP by 319.2% in the 3rd quarter. Renaissance Technologies LLC now owns 575,500 shares of the real estate investment trust’s stock valued at $15,147,000 after purchasing an additional 438,200 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in shares of HCP in the 3rd quarter valued at approximately $420,000. Pacer Advisors Inc. increased its position in shares of HCP by 14.0% in the 3rd quarter. Pacer Advisors Inc. now owns 24,929 shares of the real estate investment trust’s stock valued at $656,000 after purchasing an additional 3,060 shares during the last quarter. Finally, Vident Investment Advisory LLC increased its position in shares of HCP by 33.3% in the 3rd quarter. Vident Investment Advisory LLC now owns 52,704 shares of the real estate investment trust’s stock valued at $1,387,000 after purchasing an additional 13,166 shares during the last quarter. 95.64% of the stock is currently owned by institutional investors.
NYSE HCP opened at $29.15 on Thursday. The company has a current ratio of 0.64, a quick ratio of 0.64 and a debt-to-equity ratio of 0.85. The firm has a market capitalization of $13.98 billion, a P/E ratio of 16.02, a P/E/G ratio of 7.68 and a beta of 0.46. HCP, Inc. has a 12 month low of $21.80 and a 12 month high of $32.23.
A number of research analysts recently commented on the stock. Robert W. Baird raised shares of HCP from a “neutral” rating to an “outperform” rating in a research report on Monday, January 7th. BMO Capital Markets raised shares of HCP from a “market perform” rating to an “outperform” rating and increased their target price for the company from $30.00 to $33.00 in a research report on Wednesday, January 9th. TheStreet raised shares of HCP from a “c” rating to a “b-” rating in a research report on Wednesday, February 13th. Morgan Stanley set a $32.00 target price on shares of HCP and gave the company a “hold” rating in a research report on Thursday, March 28th. Finally, Zacks Investment Research raised shares of HCP from a “sell” rating to a “hold” rating in a research report on Thursday, March 14th. One research analyst has rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $28.95.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Read More: Special Dividends
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.